Alpha 2.0
Login Register
» Articles » PMID: 29782208

Optimal Radical Therapy for Localized Prostate Cancer: Recreation of the Self-Fulfilling Prophecy With Combination Brachytherapy?

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2018 May 22
PMID 29782208
Citations 4
Authors
Daniel E Spratt
Peter R Carroll
Affiliations
Soon will be listed here.
Citing Articles

Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial.

Hall W, Bedi M, Kilari D, Bylow K, Burfeind J, Johnstone C Pract Radiat Oncol. 2021; 11(6):527-533.

PMID: 33848618 PMC: 8638529. DOI: 10.1016/j.prro.2021.03.006.

Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study.

Pettersson A, Alm D, Garmo H, Hjelm Eriksson M, Castellanos E, Astrom L JNCI Cancer Spectr. 2020; 4(2):pkaa006.

PMID: 32373776 PMC: 7192027. DOI: 10.1093/jncics/pkaa006.

Prostate brachytherapy procedural training: incorporation of related procedures in resident training and competency assessment.

Bachand J, Schroeder S, Desai N, Folkert M J Contemp Brachytherapy. 2020; 11(6):601-606.

PMID: 31969920 PMC: 6964344. DOI: 10.5114/jcb.2019.90984.

Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial.

Macias V, Barrera-Mellado I BJU Int. 2019; 125(2):215-225.

PMID: 31614071 PMC: 7003804. DOI: 10.1111/bju.14925.